2020
DOI: 10.1016/j.ejpn.2020.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Deletion of the Williams Beuren syndrome critical region unmasks facioscapulohumeral muscular dystrophy

Abstract: Among 1339 unrelated cases accrued by the Italian National Registry for facioscapulohumeral muscular dystrophy (FSHD), we found three unrelated cases who presented signs of Williams-Beuren Syndrome (WBS) in early childhood and later developed FSHD. All three cases carry the molecular defects associated with the two disorders. The rarity of WBS and FSHD, 1 in 7500 and 1 in 20,000 respectively, makes a random association of the two diseases unlikely. These cases open novel and unexpected interpretation of geneti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

4
0

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…In the heterozygous state, a D4Z4 reduction might produce a subclinical sensitized condition that requires other epigenetic mechanisms or a contributing factor to cause overt myopathy. In some cases, it might be by the simultaneous heterozygosity for a different and recessive myopathy, as suggested by many reports in which the FSHD contractions are found in association with a second molecular defect [75,[93][94][95][96][97][98][99][100][101][102]. Alternatively, as our findings are suggesting, environmental changes that affect chromatin modifications at 4q35 could generate an abnormal quantity of subtelomeric transcripts in cells with a DRA.…”
Section: Novel Modes Of Regulation Of Telomeric 4q35 Transcripts Prov...mentioning
confidence: 53%
“…In the heterozygous state, a D4Z4 reduction might produce a subclinical sensitized condition that requires other epigenetic mechanisms or a contributing factor to cause overt myopathy. In some cases, it might be by the simultaneous heterozygosity for a different and recessive myopathy, as suggested by many reports in which the FSHD contractions are found in association with a second molecular defect [75,[93][94][95][96][97][98][99][100][101][102]. Alternatively, as our findings are suggesting, environmental changes that affect chromatin modifications at 4q35 could generate an abnormal quantity of subtelomeric transcripts in cells with a DRA.…”
Section: Novel Modes Of Regulation Of Telomeric 4q35 Transcripts Prov...mentioning
confidence: 53%
“…In the heterozygous state, a D4Z4 reduction might produce a subclinical sensitized condition that requires other epigenetic mechanisms or a contributing factor to cause overt myopathy. In some cases, it might be by the simultaneous heterozygosity for a different and recessive myopathy, as suggested by many reports in which the FSHD contractions are found in association with a second molecular defect [75,[93][94][95][96][97][98][99][100][101][102]. Alternatively, as our ndings are suggesting, environmental changes that affect chromatin modi cations at 4q35 could generate an abnormal quantity of subtelomeric transcripts in cells with a DRA.…”
Section: Figure 5 4q35 Genes Regulation Upon Different Stimuli Re Ect...mentioning
confidence: 64%
“…As shown in Table 1, the platform has been successfully applied to many different aspects of FSHD research: 1) the CCEF validation [16] 2) the genotype/phenotype characterization of people carrying specific molecular features: 1-3 DRA [14] or 7-8 DRA [21] or 9-10 [22] 3) follow up studies [23]. The MOMIS FSHD Web Platform has also been used 4) for molecular research on D4Z4 epigenetic regulation [24] or 5) to identify genetic interactions with other rare diseases [25].…”
Section: The Momis Fshd Web Platform Application In Clinical Researchmentioning
confidence: 99%